Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Oculis Holding AG	67,072.09 Bn	67,071.81 Bn	-	-31.30 Bn
2	Nanobiotix	1,925.70 Bn	1,925.64 Bn	-	-70,009.43
3	Akari Therapeutics	1,062.88 Bn	1,062.88 Bn	-	-36,186.68
4	BeOne Medicines	469.09 Bn	464.29 Bn	1.35 Bn	914.36
5	Vertex Pharmaceuticals	123.09 Bn	115.84 Bn	2.59 Bn	28.37
6	Regeneron Pharmaceuticals	70.32 Bn	61.57 Bn	3.31 Bn	15.90
7	Belite Bio	63.36 Bn	63.36 Bn	-	372.69 Bn
8	Argenx Se	55.90 Bn	50.71 Bn	1.41 Bn	32.59
9	Alnylam Pharmaceuticals	37.69 Bn	34.68 Bn	959.66 Mn	69.29
10	Revolution Medicines	37.38 Bn	37.38 Bn	-	-27.25

Download Data